According to an interim study of a large-scale clinical trial, a corona virus vaccine from the University of Oxford and AstraZeneca is 70 percent effective.
Monday’s announcement integrates data from two different active terms. When the vaccine was given in half dose and then in full dose, it was 90 percent effective. When offered in two full sizes, it showed 62 percent efficiency.
“These findings show that we have an excellent vaccine that can save many lives,” said Andrew Pollard, lead researcher at the Oxford Vaccine Test. Report. “Excitedly, we have found that one of our dosing regimens is 90 percent effective, and if this dosing regime is used, more people can be vaccinated with a planned vaccine supply.”
The findings indicate that there were 131 COVID-19 cases in the test sample, but none of those who received the vaccine were hospitalized or had severe cases.
Prime Minister of the United Kingdom Boris Johnson Tweeted: “Incredibly exciting news Oxford vaccine tests have proven to be very effective. There are still safety tests, but these are fantastic results.”
This announcement comes after the news Modern And this Pfizer / Bioendech Vaccine tests, both of which showed more than 90 percent efficacy. Moderna and Pfizer / Bioendech use MRNA technology for their vaccine, while the AstraZeneca / Oxford vaccine is a viral vector vaccine that can be stored at two to eight degrees Celsius and distributed using “existing supplies”.
The vaccine also announced on Monday that an independent data protection monitoring group had found its primary point, i.e., that it was effective.
After the press release, AstroZeneca said it was ready to send the data to regulators for conditional or initial approval. It also plans to receive a list of emergency applications from the World Health Organization. This will ensure that the vaccine is distributed in low-income countries.
UK Health Secretary Matt Hankok told Sky News that “there is a 100 million dose line in the UK, and if all goes well, it will be new in the new year.”
This article has been updated.